Treatment Evaluation of Acute Stroke for Using in Regenerative Cell Elements
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 206 participants.
Also called NCT02961504
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 206 participants
- Sponsor
- Registry
-
NCT02961504
-
- Other papers using this trial's data
- Allogeneic Stem Cell Therapy for Acute Ischemic Stroke: The Phase 2/3 TREASURE Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT02961504. Randomized; quadruple masking; primary purpose treatment. Start 2017-11-15 (actual); primary completion 2021-03-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Treatment Evaluation of Acute Stroke for Using in Regenerative Cell Elements
- Acronym
- TREASURE
- Condition
- Stroke, Acute
- Intervention (Biological)
- HLCM051
- Intervention (Biological)
- Placebo
- Lead sponsor
- Healios K.K.
Record details
- Record id
cardio:ct-nct02961504- Content hash
8259d89d1d6d2682fb69c8ee30cec8c2d1247ce52837fadea82340360bd321ab